Benign prostatic hyperplasia (BPH), the most common benign neoplasm of men, is a urinary obstructive disease characterised by the progression of lower urinary trac tsymptoms. This condition affects three of every four men in the sixth decade and 83% of men in the seventh decade of life (Wei et al., 2008)